Skip to content
Search

Latest Stories

No Smoking Day: RPS calls for more smoking cessation services in community pharmacies

Marking 'No Smoking Day' today, the Royal Pharmaceutical Society (RPS) has called for a reversal of the decommissioned smoking cessation services in community pharmacies.

RPS said 'No Smoking Day' was an opportunity for pharmacies to highlight the roles they could play in helping people quit smoking, including medicine therapies and guidance.


According to NHS Digital data from 2018, there is a decline in the number of people smoking. The number of adults still smoking is 14.4 per cent, which is above the national ambition of 12 per cent or less.

Claire Anderson, Chair of the RPS English Pharmacy Board, said: “Encouraging more people to quit smoking is one of the most important interventions that we can make to improve public health. Pharmacists and pharmacy teams are well placed to offer first point of contact help to people who want to quit but need to be fully supported to provide these services."

The RPS called for the government and NHS to bolster up public health funding “to ensure" everyone in the country could get access to such services which would help them quit through community pharmacies.

“It is good to see smoking cessation referral pilots from secondary to primary care in the Community Pharmacy Contractual Framework funding update. However, continued cuts to public health funding means that pharmacies are no longer being commissioned to provide free and accessible stop smoking services to their local communities,” Anderson added.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less